The ceRNA network highlighted core targets such as CACNB2, which were further validated by differential expression analysis intersecting drug target genes with GERD-related gene expression changes.<h4>Conclusion</h4>This study provides robust evidence of a protective effect of amlodipine against GERD, supported by genetic and molecular analyses. This evidence concerns the gene CACNB2 and gastroesophageal reflux disease.